Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Fleming

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 6, 2007
Recommended changes to oncology clinical trial design: revolution or evolution?Mark J Ratain, Rachel W Humphrey, Gary B Gordon, et al.
JCO Global Oncology|November 9, 2023
Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation MeetingBrooke E Wilson, Richard Sullivan, Richard Peto, et al.
Circulation|June 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart AssociationAna Barac, Avirup Guha, Thomas R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart AssociationAna Barac, Avirup Guha, Thomas R Fleming, et al.
Contemporary Clinical Trials|July 21, 2012
Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couplesYing Qing Chen, Benoit Masse, Lei Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2004
Tolerance and safety of different concentrations of chlorhexidine for peripartum vaginal and infant washes: HIVNET 025Craig M Wilson, Glenda Gray, Jennifer S Read, et al.
Chest|May 7, 2011
Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 studyLewis J Rubin, David B Badesch, Thomas R Fleming, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 13, 2014
Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertensionGérald Simonneau, Lewis J Rubin, Nazzareno Galiè, et al.
Chest|July 16, 2008
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survivalRaymond L Benza, Robyn J Barst, Nazzareno Galie, et al.
Journal of Inherited Metabolic Disease|May 10, 2014
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled studyChristian J Hendriksz, Barbara Burton, Thomas R Fleming, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|November 6, 2007
Recommended changes to oncology clinical trial design: revolution or evolution?Mark J Ratain, Rachel W Humphrey, Gary B Gordon, et al.
JCO Global Oncology|November 9, 2023
Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation MeetingBrooke E Wilson, Richard Sullivan, Richard Peto, et al.
Circulation|June 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart AssociationAna Barac, Avirup Guha, Thomas R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart AssociationAna Barac, Avirup Guha, Thomas R Fleming, et al.
Contemporary Clinical Trials|July 21, 2012
Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couplesYing Qing Chen, Benoit Masse, Lei Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2004
Tolerance and safety of different concentrations of chlorhexidine for peripartum vaginal and infant washes: HIVNET 025Craig M Wilson, Glenda Gray, Jennifer S Read, et al.
Chest|May 7, 2011
Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 studyLewis J Rubin, David B Badesch, Thomas R Fleming, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 13, 2014
Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertensionGérald Simonneau, Lewis J Rubin, Nazzareno Galiè, et al.
Chest|July 16, 2008
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survivalRaymond L Benza, Robyn J Barst, Nazzareno Galie, et al.
Journal of Inherited Metabolic Disease|May 10, 2014
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled studyChristian J Hendriksz, Barbara Burton, Thomas R Fleming, et al.
Pageof 11